other material
confidence high
sentiment neutral
materiality 0.60
Eloxx enters $50M at-the-market equity distribution agreement with SVB Leerink
Eloxx Pharmaceuticals, Inc.
- Up to $50M in common stock may be sold through SVB Leerink as sales agent under ATM program.
- SVB Leerink receives 3% commission on gross sales proceeds; company provides customary indemnification.
- Shares sold pursuant to existing S-3 shelf registration and prospectus supplement dated Sept 30, 2021.
- Company is not obligated to sell any shares; agreement can be terminated by either party at any time.